In breast cancer, low expressions of BTN1A1, BTN2A1, BTN2A2, BTN2A3, BTN3A1, BTN3A2, BTN3A3, BTNL2, BTNL3, and BTNL9 were significantly correlated with worse OS (Figure 5C). This evidence concerns the gene BTNL3 and breast carcinoma.